Immune checkpoints constitute a distinctive set of proteins that belong to the B7 family. The engagement of these transmembrane receptors with their ligands provides critical signals to inhibit T-cell ... these…
death‑1 (PD-1). Activation of the immune system by inhibiting T-cell checkpoints may cause immune-mediated toxicity, which may be serious and potentially fatal. Abnormal hepatic biochemical tests
cells also express other receptors that inhibit their proliferation and cytokine production, known as immune checkpoints. Among these receptors are Cytotoxic T Lymphocyte Antigen-4 (CTLA-4), programmed death
sMIC with B10G5 also enhanced the efficacy of other cancer immunotherapeutic modalities, such as immune checkpoint blockade or adoptive cell-based therapy pre-clinically. Our study has launched
Yervoy, Keytruda). S-TIR™ vaccines fully activate both arms of the patient’s own immune system resulting in tumour specific polyclonal IgG responses simultaneously with the generation and activation ... patient to…
drugs stimulate the immune system to destroy tumor cells. Immunotherapy includes medications that target immune checkpoints. Immune checkpoint inhibitors are specific antibodies that target immune checkpoints. In this…
Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment by leveraging the body’s own immune system to fight cancer cells. This review article delves into the mechanisms ... immune checkpoints…
Background: Targeting the immune checkpoints cytotoxic T-lymphocyteassociated protein 4 (CTLA-4) and programmed death 1 (PD-1) with inhibitory antibodies has demonstrated effective and durable antitumor activity in…
attenuation of immune responses to tumors. Siglecs are mostly inhibitory receptors similar to known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies ... cancer…
attenuation of immune responses to tumors. Siglecs are mostly inhibitory receptors similar to known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies ... cancer…
Endocrine complications arising from the use of immune checkpoint inhibitors present unique challenges in oncology and require specialized diagnostic and management strategies. This article provides a comprehensive…
regulation of anti-tumor responses by immune-checkpoint blockade is a new approach for the treatment of advanced solid malignant tumors. There are some demerits to this therapy that require ... eligibility and efficacy…
Induced Sarcoid Like Reactions (DISR) have recently been described as a potential consequence of immune checkpoint inhibitor therapy. However, hypercalcemia associated with DISR has not been reported. Clinical case…
Immune checkpoint blockade plays a crucial role in mounting antitumor immunity thereby improving cancer survival. Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) and cytotoxic…
Purpose: Antibodies that target immune checkpoint molecules have demonstrated significant and durable clinical benefit through re-activation and proliferation of pre-existing tumor-infiltrating CD8+ T cells in a broad…
inconspicuous. Purpose: We aimed to explore the potential favourable roles of chemotherapy in promoting immune checkpoint blockade therapy in non-small cell lung cancer (NSCLC). Method: We combined chemotherapy…
Immune checkpoint inhibitors (ICIs) targeting PD-1 (programmed cell death-1) and CTLA-4 (cytotoxic T-lymphocyte antigen-4) have revolutionized cancer immunotherapy, providing durable responses in various cancers…
Cancer immunotherapy has revolutionized the treatment landscape, with Immune Checkpoint Inhibitors (ICIs) playing a pivotal role in harnessing the body's immune system to combat cancer. However, not all patients…
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by harnessing the immune system to target tumors, leading to durable responses in various malignancies. However, the efficacy of ICIs varies…
relapsed cases. Recent insights into tumor immunology have led to the exploration of immune checkpoint inhibitors and biomarker-driven strategies to personalize treatment. This article examines the role of immune…
realm of cancer treatment, Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic approach, marking a significant paradigm shift in cancer immunology. These inhibitors target key regulatory…
promising approach for treating various malignancies. Among the diverse strategies within this field, targeting immune checkpoints has gained significant attention due to its ability to unleash the body's immune…
Background: Immune checkpoint inhibitors have become part of the standard of care for many forms of solid tumors. Most immune checkpoint inhibitors target the PD (Programmed Cell Death
cancers. Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.